Subclinical nephrotoxicity in patients with beta-thalassemia: role of urinary kidney injury molecule.

Nafea, Ola E; Zakaria, Marwa; Hassan, Tamer; El Gebaly, Sherif M; Salah, Hosam E

Nafea, Ola E; Zakaria, Marwa; Hassan, Tamer; El Gebaly, Sherif M; Salah, Hosam E.

Afiliación

Nafea OE; Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Zakaria M; Department of Pediatrics, Faculty of Medicine, Zagazig University, Egypt.
Hassan T; Department of Pediatrics, Faculty of Medicine, Zagazig University, Egypt.
El Gebaly SM; Department of Pediatrics, Faculty of Medicine, Zagazig University, Egypt.
Salah HE; Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

Drug Chem Toxicol ; 45(1): 93-102, 2022 Jan.

Article en En | MEDLINE | ID: mdl-31905029

Asunto(s)

Sobrecarga de Hierro; Talasemia beta; Adolescente; Adulto; Niño; Estudios Transversales; Deferasirox; Deferoxamina/efectos adversos; Humanos; Quelantes del Hierro/efectos adversos; Riñón; Adulto Joven; Talasemia beta/complicaciones; Talasemia beta/tratamiento farmacológico

Palabras clave

Beta-thalassemia; Iron overload; KIM-1; chelation; deferasirox

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Talasemia beta / Sobrecarga de Hierro Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Drug Chem Toxicol Año: 2022 Tipo del documento: Article País de afiliación: Egipto

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google